Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (1), 137-144
- https://doi.org/10.1016/s0168-8278(02)00115-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Durable HBeAg and HBsAg seroconversions after lamivudine for chronic hepatitis B (CHB)Journal of Hepatology, 2000
- Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in KoreaHepatology, 2000
- Use of the Hepatitis B Virus Recombinant Baculovirus-HepG2 System to Study the Effects of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine on Replication of Hepatitis B Virus and Accumulation of Covalently Closed Circular DNAAntimicrobial Agents and Chemotherapy, 1999
- Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 1999
- In Vitro Inhibition of Hepadnavirus Polymerases by the Triphosphates of BMS-200475 and LobucavirAntimicrobial Agents and Chemotherapy, 1998
- Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virusAntimicrobial Agents and Chemotherapy, 1997
- The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trialsJournal of Hepatology, 1994
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhoodGastroenterology, 1990
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981